Historique
Auteur H. HAGAN
Documents disponibles écrits par cet auteur (44)
Ajouter le résultat à votre sélection Affiner la recherche
H. HAGAN ; D. C. DES JARLAIS ; D. PURCHASE ; S. R. FRIEDMAN ; T. REID ; T. A. BELL | 1993
Dans Addiction (Vol.88, n°12, December 1993) Article : PériodiqueFRANÇAIS : Nous faisons ici le compte rendu de la mise en oeuvre et de l'efficacité potentielle de la plus longue opération d'échange de seringues fonctionnant aux USA, de même que nous comparons nos résultats à ceux d'études portant sur des p[...]
D. C. DES JARLAIS ; J. P. FEELEMYER ; S. N. MODI ; K. ARASTEH ; H. HAGAN | 2012
Dans Drug and Alcohol Dependence (Vol.124, n°1-2, July 2012) Article : PériodiqueObjective: There are multiple reasons why females who inject drugs may be more likely to become infected with HIV than males who inject drugs. Where this is the case, special HIV prevention programs for females would be needed. Design: Internat[...]
D. C. DES JARLAIS ; D. PAONE ; MILLIKEN J. ; C. F. TURNER ; H. MILLER ; GRIBBLE J. ; SHI Q. ; H. HAGAN ; S. R. FRIEDMAN | 1999
PériodiqueFRANÇAIS : Une méthode d'entretien (audio-CASI) par ordinateur où les questions sont posées sur l'écran et en même temps à l'aide d'un casque audio et les réponses données par sélection sur le clavier, permet de réduire les sous-déclarations. D[...]
D. C. DES JARLAIS ; H. HAGAN ; K. ARASTEH ; C. McKNIGHT ; S. SEMAAN ; D. C. PERLMAN | 2011
Dans Drug and Alcohol Dependence (Vol.119, n°3, December 2011) Article : PériodiqueBACKGROUND: Preventing HCV infection among people who inject drugs is a difficult public health challenge. We examined the potential role of intranasal drug use in reducing HCV acquisition. METHODS: Subjects were recruited from IDUs entering t[...]
ENGLISH : Drug treatment programs are uniquely situated to screen patients for antibodies for hepatitis C virus (HCV), an infectious disease that has reached epidemic proportions among drug users. This paper compares the accessibility and pati[...]
S. M. JENNESS ; H. HAGAN ; K. L. LIU ; T. WENDEL ; C. S. MURRILL | 2011
Dans Substance Use and Misuse (Vol.46, n°2-3, 2011) Article : PériodiqueSterile syringe access is an important means to reduce HIV risk, but many injection drug users (IDU) who obtain syringes from sterile sources continue to share syringes. We examined the factors associated with continuing syringe sharing in New Y[...]
S. DEREN ; H. HAGAN ; S. FRIEDMAN ; D. C. DES JARLAIS ; D. PERLMAN ; M. GWADZ ; C. CLELAND ; A. OSBORNE ; J. LUNIEVICZ | 2011
Dans Substance Use and Misuse (Vol.46, n°2-3, 2011) Article : PériodiqueAs we begin the fourth decade of the epidemic, it is clear that, as demonstrated by the articles in this Special Issue, much has been learned about factors contributing to the decline in HIV prevalence among drug users in New York. However, ther[...]
ENGLISH : Psychological depression has been identified as a condition that may influence HIV risk behavior among injection drug users (IDUs) and men who have sex with men (MSM). In two Seattle studies,1,228 IDUs and 429 young MSM completed the[...]
ENGLISH : Psychological depression has been identified as a condition that may influence HIV risk behavior among injection drug users (IDUs) and men who have sex with men (MSM). In two Seattle studies,1,228 IDUs and 429 young MSM completed the[...]
S. M. STRAUSS ; J. ASTONE-TWERELL ; C. E. MUNOZ-PLAZA ; D. C. DES JARLAIS ; M. GWADZ ; H. HAGAN ; A. OSBORNE ; A. ROSENBLUM | 2007
Dans BMC Health Services Research (Vol.7, n°39, 2007) Article : PériodiqueBACKGROUND: In spite of the disproportionate prevalence of hepatitis C virus (HCV) infection among drug users, many remain uninformed or misinformed about the virus. Drug treatment programs are important sites of opportunity for providing HCV ed[...]
ENGLISH : This paper uses qualitative methods to examine both staff and clients perceptions about the delivery of hepatitis C prevention education services at their respective residential drug treatment programs. Through in-depth discussion wi[...]
ENGLISH : Hepatitis C virus (HCV) infection is the most common blood-borne infectious disease among drug users in the US. Drug treatment programs are ideally situated to assist their clients to obtain HCV medical and support services. Using da[...]![Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs [Protocol]](https://bdoc.ofdt.fr/thumbnail.php?type=1&id=77326)
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN | 2016
Dans Cochrane Database of Systematic Reviews (n°1, 2016) Article : PériodiqueThis is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]
H. HAGAN ; M. H. LATKA ; J. V. CAMPBELL ; E. T. GOLUB ; R. S. GARFEIN ; D. A. THOMAS ; F. KAPADIA ; S. A. STRATHDEE | 2006
PériodiqueENGLISH : Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depres[...]
